PEABODY, Mass., Nov. 27, 2016 -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, today announced that it will introduce bkFusion1, a groundbreaking solution for improving biopsy targeting in prostate cancer, at the 102nd Annual Meeting of the Radiological Society of North America (RSNA). bkFusion is the latest innovation from the company’s flagship BK Ultrasound brand. It is the first MR-fusion biopsy application, fully integrated into BK Ultrasound’s bk3000 premium ultrasound system designed uniquely for use by urologists for both hospital and office settings.
Targeting subtle prostate lesions for biopsy is difficult with ultrasound alone. bkFusion seamlessly overlays MR image information about lesion location and extent onto real-time ultrasound images, without the need for an additional workstation. This improves workflow and minimizes the system’s footprint, which are significant benefits for the urologist performing biopsies in the office, enabling faster and more reliable disease management.
BK Ultrasound, powered by Analogic, has partnered with MIM Software Inc., a provider of market-leading imaging solutions for radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging, to create bkFusion. The innovative software builds on MIM’s unique Predictive Fusion technology to enable the urologist to precisely biopsy MR-defined targets in less time and with more accuracy than a traditional ultrasound-only biopsy approach. With its small footprint, the bk3000 fits easily into any office space and because bkFusion is completely integrated on the ultrasound system, no additional bulky equipment or set-up time is required. The system communicates easily with radiology departments, accessing the MR images via PACS or a secure cloud platform.
“We are very pleased to launch a ground-breaking new solution for the Urology community in partnership with MIM” said Jacques Coumans PhD, VP, chief marketing & scientific officer. “Our customers are our best guide for break-through innovation. Complementing MIM’s leadership in medical image processing for cancer visualization with our strength in specialty ultrasound has created a solution our customers have been looking for. Current solutions for MR-fusion have had MR at the center of the workflow. With bkFusion, we put real-time ultrasound as the focus of our Urology-centered approach. The MR information helps point urologists more precisely to their target, and the prostate image quality provided by the bk3000 helps urologists visualize and revalidate subtle lesions.”
“We are excited to partner with BK Ultrasound to bring this innovative application to Urology,” said, Jon Piper, VP of R&D from MIM. “bkFusion makes it possible to harness the power of MR imaging in the Urology office, providing patients with the clinical benefits of a more targeted biopsy in the privacy and comfort of their physician’s practice setting. Our approach has always been to focus on technology that benefits the greatest number of patients possible by being practical for use in centers of any size.”
Analogic will also showcase its newest innovative products that deliver to OEMs breakthrough reliability and lowest cost of ownership in their CT, MRI, and digital mammography offerings. Featured products will include its 64-slice, 85-cm bore CT gantry, equipped with LISA (Low Dose Imaging Software by Analogic); its latest 1.5T RF amplifier for MRI; and its newest Selenium-based, direct-digital detector for mammography.
Visit Analogic at Booth #6124 during RSNA 2016. More information may be found at www.analogic.com.
About Analogic
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging and real-time guidance technologies used for disease diagnosis and treatment as well as for automated threat detection. Our market-leading ultrasound systems, led by our flagship BK Ultrasound brand, used in procedure-driven markets such as urology, surgery, and point-of-care, are sold to clinical practitioners around the world. Our advanced imaging technologies are also used in computed tomography (CT), magnetic resonance imaging (MRI) and digital mammography systems, as well as automated threat detection systems for aviation security. Analogic is headquartered just north of Boston, Massachusetts. For more information, visit www.analogic.com.
1 Expected availability in early 2017.
Analogic and the globe logo are registered trademarks, and BK Ultrasound and bkFusion are trademarks, of Analogic Corporation or its affiliated companies.
For further information, please contact:
Investor Contact:
Mark Namaroff
Director of Investor Relations
(978) 326-4058
[email protected]
Media Contact:
Judith Rossi
Sr. Director, Marketing Communications
(978) 317-5172
[email protected]


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
First Western Ship Transits Strait of Hormuz Since Iran War Began
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 



